dactinomycin has been researched along with Bacterial Disease in 36 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (2.78) | 18.7374 |
1990's | 28 (77.78) | 18.2507 |
2000's | 5 (13.89) | 29.6817 |
2010's | 2 (5.56) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, HW; Chang, YT; Cheng, BC; Cheng, HH; Chiang, YF; Hsiao, SY; Kung, CT; Lin, WC; Lu, CH; Su, CM; Su, YJ; Tsai, NW; Tsai, TC; Wang, HC | 1 |
Duma, RJ | 1 |
Ikawa, K; Ikeda, K; Morikawa, N; Nomura, K; Ohge, H; Sueda, T; Taniwaki, M | 1 |
Ariga, T; Cho, Y; Ichikawa, M; Iguchi, A; Kaneda, M; Ohshima, J; Suzuki, D | 1 |
Ookubo, H | 1 |
Fujimoto, Y; Fujita, N; Ikawa, K; Ikeda, K; Kanbayashi, Y; Komori, T; Matsumoto, Y; Morikawa, N; Nomura, K; Shimazaki, C; Shimizu, D; Shimura, K; Taniguchi, K; Taniwaki, M | 1 |
Fujii, R; Meguro, H; Terashima, I | 1 |
Abe, T; Hagiwara, N; Iizuka, T; Kawashima, S; Kondo, Y; Kubota, K; Negishi, S; Tajima, T | 1 |
Niinou, K; Sato, H | 1 |
Akita, H; Iwata, S; Sato, Y; Sunakawa, K; Yokota, T | 1 |
Hatakeyama, K; Ishihara, T; Kawamura, K; Nakamura, H; Sano, T; Seo, K; Toyonaga, Y | 1 |
Iwai, N; Miyazu, M; Nakamura, H; Taneda, Y; Watanabe, Y | 1 |
Azuma, E; Ihara, T; Itoh, M; Kamiya, H; Kitamura, K; Sakurai, M | 1 |
Aoki, S; Nishimura, T; Tabuki, K; Takagi, M | 1 |
Haruta, T; Kobayashi, Y; Kuroki, S; Nikami, H; Okura, K | 1 |
Higashino, H; Ishizaki, Y; Kino, M; Kobayashi, Y; Man, W; Takaya, J; Taniuchi, S | 1 |
Kaino, Y; Kida, K; Matsuda, H | 1 |
Arai, J; Fujieda, M; Hosokawa, T; Maeda, H; Morisawa, Y; Morita, H; Nagao, A; Shinohara, M; Takeda, K; Watanabe, S | 1 |
Okamoto, T; Sekiguchi, T | 1 |
Aramaki, M; Handa, S; Motohiro, T; Oda, K; Oki, S; Sakata, Y; Sasaki, H; Yamada, S; Yamashita, F; Yoshinaga, Y | 1 |
Abe, T; Fujii, R; Meguro, H; Nakazawa, S; Niinou, K; Sato, H; Sunakawa, K; Tajima, T; Terashima, I; Yokota, T | 1 |
Akita, H; Fujii, R; Iwai, N; Iwata, S; Kobayashi, Y; Kuno, K; Meguro, H; Nishimura, T; Sunakawa, K; Toyonaga, Y | 1 |
Hayashi, R; Iizawa, Y; Imada, A; Iwahi, T; Okonogi, K; Yamazaki, T | 1 |
Fujii, R; Fujiwara, T; Inui, T; Ishihara, T; Itoh, M; Iwai, N; Kamiya, H; Kawaoi, Y; Kawasaki, H; Kondoh, Y; Kuno, K; Meguro, H; Miyajima, Y; Nakamura, H; Nakayama, M; Niinou, K; Sakurai, M; Sato, Y; Suga, S; Sunakawa, K; Taniguchi, K; Terashima, I; Toyonaga, Y; Yokota, T; Yoshimura, K | 1 |
Abe, T; Fujii, R; Fujita, K; Funamoto, N; Hashira, S; Inyaku, F; Kakuya, F; Kantake, M; Kawaoi, Y; Kondoh, Y; Maruyama, S; Meguro, H; Nagai, S; Nakazato, Y; Nishimura, S; Okuno, A; Sakata, H; Sugimori, S; Sugiura, M; Sunakawa, K; Tajima, T; Takeuchi, Y; Terashima, I; Yagisawa, M; Yoshimura, K | 1 |
Abe, T; Fujii, R; Meguro, H; Tajima, T; Terashima, I | 1 |
Hara, K; Kobayashi, H; Moritono, S | 1 |
Akita, H; Iwata, S; Kusumoto, Y; Sato, Y; Sunakawa, K; Yokota, T | 1 |
Abe, T; Funamoto, N; Hashira, S; Kawaoi, Y; Kondoh, Y; Nagai, S; Nakazato, Y; Nishimura, S; Sugimori, S; Sugiura, M; Tajima, T; Yoshimura, K | 1 |
Kantake, M; Meguro, H; Takeuchi, Y; Terashima, I | 1 |
Fujimoto, T; Hashimoto, T; Hayashi, M; Kamizono, S; Matsuo, Y; Morita, J; Motohiro, T; Nagai, K; Sakata, Y; Takagishi, T; Toyota, A; Wada, M; Yoshinaga, Y | 1 |
Fukuda, M; Hayashi, K; Kusumoto, T; Nakashita, S; Takayanagi, T; Tanaka, H; Tomimasu, K; Tsuji, Y; Yoshinaga, M | 1 |
Horiike, S; Iwai, T; Kaneko, H; Kashima, K; Misawa, S; Nakazawa, N; Ohgawara, Y; Sasai, Y; Tamura, A; Taniwaki, M; Tsuda, S; Ueda, Y; Yokota, S | 1 |
Aoki, K; Asano, S; Bessho, M; Fujita, A; Furusawa, S; Higashihara, M; Hirai, H; Hoshino, S; Hotta, T; Kitamura, K; Koike, M; Kuraishi, Y; Kurihara, I; Mizoguchi, H; Nagoshi, H; Nishimura, M; Nonaka, Y; Ohbayashi, Y; Omine, M; Oshimi, K; Ozawa, K; Suzuki, K; Takaku, F; Togawa, A; Urabe, A; Wakabayashi, Y | 1 |
Bessho, M; Endo, K; Fukuda, M; Kawai, N; Maesaki, S; Takinami, S; Tominaga, K; Yamazaki, T | 1 |
Imada, A; Iwahi, T; Kondo, M; Miyake, A; Okonogi, K; Shiki, S; Yamazaki, T | 1 |
27 trial(s) available for dactinomycin and Bacterial Disease
Article | Year |
---|---|
Piperacillin/tazobactam versus cefozopran for the empirical treatment of pediatric cancer patients with febrile neutropenia.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Cefozopran; Cephalosporins; Child; Child, Preschool; Female; Fever; Humans; Male; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2011 |
Optimized dosage and frequency of cefozopran for patients with febrile neutropenia based on population pharmacokinetic and pharmacodynamic analysis.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefozopran; Cephalosporins; Female; Fever; Hematologic Neoplasms; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Models, Statistical; Monte Carlo Method; Neutropenia; Plasma | 2008 |
[Clinical evaluation of cefozopran in the pediatric field].
Topics: Acute Disease; Bacterial Infections; Cefozopran; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Male | 1994 |
[Pharmacokinetic, bacteriological and clinical studies on cefozopran in children].
Topics: Bacteria; Bacterial Infections; Cefozopran; Cephalosporins; Child; Child, Preschool; Drug Resistance, Microbial; Female; Humans; Infant; Infusions, Intravenous; Injections, Intravenous; Male | 1994 |
[Studies on cefozopran in the pediatric field].
Topics: Bacterial Infections; Cefozopran; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Infusions, Intravenous; Male | 1994 |
[Pharmacokinetic and clinical studies on cefozopran in pediatrics].
Topics: Adolescent; Bacterial Infections; Blood Coagulation; Cefozopran; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Infusions, Intravenous; Injections, Intravenous; Male | 1994 |
[Pharmacokinetic and clinical evaluation of cefozopran in the pediatric field].
Topics: Adolescent; Bacterial Infections; Cefozopran; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Infusions, Intravenous; Injections, Intravenous; Male | 1994 |
[Pharmacokinetic and clinical evaluation of cefozopran in the pediatric field].
Topics: Acute Disease; Adolescent; Bacterial Infections; Cefozopran; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Injections, Intravenous; Male | 1994 |
[Pharmacokinetic and clinical studies of cefozopran in the field of pediatrics].
Topics: Adolescent; Bacteria; Bacterial Infections; Cefozopran; Cephalosporins; Child; Child, Preschool; Drug Resistance, Microbial; Female; Humans; Infant; Male | 1994 |
[Bacteriological and clinical studies on cefozopran in pediatric field].
Topics: Bacteria; Bacterial Infections; Cefozopran; Cephalosporins; Child; Child, Preschool; Drug Resistance, Microbial; Female; Humans; Infant; Male | 1994 |
[Clinical studies on cefozopran in pediatrics].
Topics: Adolescent; Bacterial Infections; Cefozopran; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Injections, Intravenous; Male | 1994 |
[Clinical evaluation of a new parenteral cephem, cefozopran, in children].
Topics: Bacteria; Bacterial Infections; Cefozopran; Cephalosporins; Child; Child, Preschool; Drug Resistance, Microbial; Female; Humans; Infant; Infusions, Intravenous; Male | 1994 |
[Pharmacokinetic and clinical studies on cefozopran in the field of pediatrics].
Topics: Bacteria; Bacterial Infections; Cefozopran; Cephalosporins; Child; Child, Preschool; Drug Resistance, Microbial; Female; Humans; Infant; Injections, Intravenous; Male | 1994 |
[Clinical studies on cefozopran in pediatrics].
Topics: Adolescent; Bacterial Infections; Cefozopran; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Infusions, Intravenous; Male | 1994 |
[Clinical studies on cefozopran in pediatrics].
Topics: Bacteria; Bacterial Infections; Cefozopran; Cephalosporins; Child; Child, Preschool; Drug Resistance, Microbial; Female; Humans; Infant; Infusions, Intravenous; Injections, Intravenous; Male | 1994 |
[Pharmacokinetic, bacteriological and clinical studies on cefozopran in the pediatric field].
Topics: Bacteria; Bacterial Infections; Cefozopran; Cephalosporins; Child; Child, Preschool; Drug Resistance, Microbial; Female; Humans; Infant; Infusions, Intravenous; Injections, Intravenous; Male | 1994 |
[Pharmacokinetic and clinical studies with cefozopran in the pediatric field. Pediatric Study Group of Cefozopran].
Topics: Adolescent; Bacteria; Bacterial Infections; Cefozopran; Cephalosporins; Child; Child, Preschool; Diarrhea; Drug Eruptions; Female; Half-Life; Humans; Infant; Japan; Male; Meningitis, Bacterial; Respiratory Tract Infections; Urinary Tract Infections | 1994 |
[Optimum dose study of cefozopran in the pediatric field].
Topics: Bacterial Infections; Cefozopran; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Male; Pneumonia, Bacterial | 1996 |
[Pharmacokinetic, bacteriological and clinical studies on cefozopran in neonates and premature infants. A study of cefozopran in the perinatal co-research group].
Topics: Bacterial Infections; Cefozopran; Cephalosporins; Female; Humans; Infant, Newborn; Infant, Premature, Diseases; Male | 1996 |
[Fundamental and clinical evaluation of cefozopran in low birth weight infants and neonates].
Topics: Bacterial Infections; Cefozopran; Cephalosporins; Female; Half-Life; Humans; Infant, Low Birth Weight; Infant, Newborn; Infusions, Intravenous; Injections, Intravenous; Male | 1997 |
[Pharmacokinetic, bacteriological and clinical studies on cefozopran in neonates].
Topics: Bacterial Infections; Cefozopran; Cephalosporins; Female; Half-Life; Humans; Infant, Newborn; Infusions, Intravenous; Injections, Intravenous; Male | 1997 |
[Pharmacokinetic, bacteriological and clinical studies on cefozopran in neonates].
Topics: Bacterial Infections; Cefozopran; Cephalosporins; Female; Half-Life; Humans; Infant, Newborn; Infusions, Intravenous; Injections, Intravenous; Male | 1997 |
[Pharmacokinetic and clinical evaluation of cefozopran in premature and newborn patients].
Topics: Bacterial Infections; Cefozopran; Cephalosporins; Female; Half-Life; Humans; Infant, Newborn; Infant, Premature; Infusions, Intravenous; Injections, Intravenous; Male | 1997 |
[Pharmacokinetic and clinical evaluation of cefozopran in newborn patients].
Topics: Bacterial Infections; Cefozopran; Cephalosporins; Female; Half-Life; Humans; Infant, Newborn; Injections, Intravenous; Male | 1997 |
[Clinical evaluation of cefozopran for infections associated with hematological malignancies].
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anemia, Aplastic; Bacterial Infections; Bronchitis; Cefozopran; Cephalosporins; Female; Granulocytes; Hodgkin Disease; Humans; Leukemia; Leukemia, Myeloid, Acute; Leukemia, T-Cell; Leukocyte Count; Lymphoma; Male; Middle Aged; Multiple Myeloma; Peritonitis; Pneumonia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sepsis; Severity of Illness Index | 1998 |
[Efficacy and safety of cefozopran (CZOP) monotherapy and combination therapy with CZOP and amikacin (AMK) for infections accompanying hematological diseases].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cefozopran; Cephalosporins; Drug Therapy, Combination; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Male; Middle Aged; Pneumonia, Bacterial; Sepsis | 2000 |
[Clinical effects of combination therapy with cefozopran and amikacin for infections in patients with hematological disorders].
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Cefozopran; Cephalosporins; Drug Therapy, Combination; Female; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Humans; Immunocompromised Host; Male; Middle Aged; Opportunistic Infections; Treatment Outcome | 2001 |
9 other study(ies) available for dactinomycin and Bacterial Disease
Article | Year |
---|---|
The prognostic value of leukocyte apoptosis in patients with severe sepsis at the emergency department.
Topics: Aged; Aged, 80 and over; Annexin A5; Apoptosis; Apoptosis Regulatory Proteins; Bacterial Infections; Case-Control Studies; Cells, Cultured; Critical Illness; Dactinomycin; Emergency Service, Hospital; Female; Flow Cytometry; Fluorescent Dyes; Humans; Lactic Acid; Leukocytes; Male; Middle Aged; Mitochondrial Proteins; Monocytes; Prognosis; Prospective Studies; Sepsis; Survival Analysis | 2015 |
Unusual infections in transplant patients.
Topics: Adolescent; Adult; Agammaglobulinemia; Azathioprine; Bacterial Infections; Bis-Trimethylammonium Compounds; Dactinomycin; Female; Graft Rejection; Humans; Kidney Transplantation; Lung; Male; Mycoses; Nocardia asteroides; Pneumonia, Pneumocystis; Prednisone; Radiography; Transplantation, Homologous | 1972 |
Pharmacokinetic-pharmacodynamic target attainment analysis of cefozopran in Japanese adult patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefozopran; Cephalosporins; Female; Humans; Laparotomy; Male; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Neutropenia | 2008 |
[Outline of the drug use result survey of Firstcin (cefozopran hydrochloride) as part of postmarketing surveillance in Japan].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Cefozopran; Cephalosporins; Child; Child, Preschool; Data Collection; Female; Humans; Infant; Injections; Japan; Male; Middle Aged; Product Surveillance, Postmarketing | 2005 |
[Criteria for clinical evaluation of antibiotics in pediatrics. The purpose and process for establishing the criteria].
Topics: Bacterial Infections; Cefozopran; Cephalosporins; Child; Clinical Trials as Topic; Humans; Pediatrics | 1993 |
Therapeutic effect of cefozopran (SCE-2787), a new parenteral cephalosporin, against experimental infections in mice.
Topics: Animals; Bacterial Infections; Cefozopran; Cephalosporins; Female; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mice, Inbred CBA; Mice, Inbred ICR; Muscular Diseases; Pseudomonas Infections; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus aureus; Urinary Tract Infections | 1993 |
Pharmacokinetics and clinical effects of cefozopran in pediatric patients.
Topics: Bacteria; Bacterial Infections; Cefozopran; Cephalosporins; Child; Humans | 1996 |
[Significant role of new cephem antibiotics: Focused on cefozopran].
Topics: Animals; Bacterial Infections; Cefozopran; Cephalosporins; Humans | 1997 |
In vitro and in vivo activities of SCE-2787, a new parenteral cephalosporin with a broad antibacterial spectrum.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamases; Cefozopran; Cephalosporins; Gram-Negative Bacteria; Mice; Microbial Sensitivity Tests | 1992 |